Virbac — Capital/Financing Update 2010

Mar 5, 2010

VIRBAC enters into an alliance in food-producing animals vaccines

CARROS, France – March 5, 2010

Virbac has entered into a strategic alliance in food-producing animals vaccines by taking a 30% shareholding in the Uruguayan laboratory Santa Elena. This company is established in Uruguay since more than 50 years and enjoys a large expertise in the development and manufacturing of vaccines, essentially for bovine, which are marketed in Uruguay and Latin American countries. Its revenues reached 7 million US dollars in 2009.

Virbac will have the possibility to ultimately acquire whole of the capital stock of Santa Elena.

With this alliance, Santa Elena will be able to use the solid commercial platform brought by Virbac and introduce its vaccines range in many markets abroad. Virbac on its side will benefit from Santa Elena's skills and know-how in biology to help building up a development and manufacturing base for food-producing animals vaccines, allowing Virbac's entry into this market segment.